Health/Disease Strategy

New public opinion survey about opioid use from Prime Therapeutics has surprising results.

Unique partnerships between payers and providers focus on keeping patients out of the hospital and on the road to remission.

Moffitt Cancer Center expert shares her thinking on managing chemotherapy-related side effects.

Education is a significant element of comprehensive care for COPD patients. In this Q&A, one expert shares her recommendations.

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Healthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.

New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.

Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

A Physicians Foundation survey gives healthcare executives behind the scenes insight into the physician-patient relationship.

CAR-T therapies have high price tags so it’s important to understand your patient population and budget impact.

Providers are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.

Here’s how to take consumer-centricity more seriously as expectations increase.

Acute myeloid leukemia experts share promising new developments on the oncology horizon.

A new study uses population health analytics to identify potential opioid abuse, and the study findings are troubling.

Recent study findings reveal which patients are more likely to be readmitted for COPD problems, and which readmission reduction strategies might work best.

To succeed as a Next Generation ACO, Indiana University Health system is changing its COPD care management approach.

An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.

Now that the Graham-Cassidy bill has failed, here’s what healthcare executives should do to plan for 2018.

A new study has shocking results about beta blocker use in heart-attack survivors.

A new HealthMine survey sheds light on how payers can better connect Medicare members to their health plan.

A survey from HealthScape Advisors and the Health Plan Alliance has revealing findings about value-based payment models.

A new poll has interesting findings related to patient preferences and needs. Read more.

Universal healthcare is top of mind for healthcare stakeholders. Here’s four things you need to know about it right now.

A new study from The Ohio State University reveals eye-opening findings about individuals with developmental disabilities.

A new report from West has surprising findings about high-deductible health plans and insurance coverage.

Here are 5 things to know about GPOs, their business model and role in the supply chain, and their impact on healthcare costs and competition

A study from Humana and the CDC sheds eye-opening results about arthritis and health-related quality of life.

This new hospital model offers an opportunity to attract new patients in an efficient, cost-effective setting.

The first therapy based on gene transfer has been approved by the FDA. What’s next for healthcare executives?